IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q4 2022 Holdings

Filed 2023-02-14 | 11 holdings | $840.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alkermes PLC(ALKS)SHSG01767105$234.2M8,964,64027.9%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$203.1M16,390,00024.2%
Biogen Inc(BIIB)COM09062X103$178.1M643,00021.2%
Gilead Sciences Inc(GILD)COM375558103$91.8M1,068,75010.9%
Innoviva Inc(INVA)COM45781M101$87.6M6,614,00010.4%
Mersana Therapeutics IncCOM59045L106$23.4M3,997,0102.8%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$11.3M980,2881.3%
Amarin Corp PLCSPONS ADR NEW023111206$5.8M4,807,0000.7%
VOR Biopharma IncCOM929033108$4.1M618,0000.5%
Pear Therapeutics IncCLASS A COM704723105$590.4K500,3560.1%
Regulus Therapeutics Inc(RGLS)COM75915K309$253.7K185,1830.0%